 pancreatic cancer, for example, or gallbladder cancer in young and old diagnosed individuals. And so I think there's still a lot that we can learn from the molecular, the histological characterization of these tumors to understand whether there are differences. And not only whether the causes are different, but whether the tumors are different enough that we might want to manage or treat them differently.